INS and metabolic disease: These metabolite disruptions predispose Mof+/− mice to developing metabolic disorders, as confirmed by physiological indicators including impaired glucose assimilation, reduced insulin secretion and elevated glycated-hemoglobin (Hb1ac) levels in these animals.